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Abstract 
Age-related dynamics of body homeostasis individual indicators in patients with risk of developing 
frailty and without frailty was studied in the research. Clinical indicators mostly associated with age 
were determined: muscle strength, glomerular filtration rate, total protein, potassium, hemoglobin, 
alanine aminotransferase activity, and blood plasma glucose. The contribution of reduced overall 
renal function, as well as anabolic activity of the liver in the development of age-related changes and 
frailty was studied. The important role of the renal function condition in the development of geriatric 
syndromes was noted, which must be taken into account when conducting therapeutic and 
rehabilitation measures for elderly and senile patients. It was noted that age-associated integral 
indicators, such as body weight and muscle strength, change noticeably more significantly than 
individual biochemical constants. This confirms the multiple nature of pathogenetic mechanisms and 
the role of comorbidity in the formation of geriatric syndromes, in particular, frailty. 
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INTRODUCTION 
Currently, much attention is paid to improving 
geriatric care for elderly and senile patients. At the same 
time, a wide range of specific features arises in medical 
and social support for this category of patients. The 
problem of geriatric care is multidisciplinary, requiring 
consideration of medical, social and psychological 
aspects in patient management. In the vast majority of 
cases, management of elderly and senile patients falls 
on the specialists of the therapeutic and surgical profile 
without special training in the area of gerontology. A 
specific feature of elderly and senile patients is the 
presence of comorbidity, polypharmacy in the picture 
(Lazebnik, Efremov, Konev, 2015- Prashchayeu, 
Ilnitski,, Pozdnyakova et al., 2016- Tkacheva, et al. 2017 
Bonnefoy, Berrut,, Lesourd, et al., 2015- Gorelik et al. 
2018- Koroukian, et al., 2017 Bezdenezhnykh, Sumin, 
2012- Paddon-Jones, & Leidy, 2014), as well as special 
geriatric conditions, mostly frailty and functional 
deficiency syndrome (Pathak, Jain, Jaiswal, et al., 2016- 
Tkacheva, Runikhina, Ostapenko, et al., 2017- 
Tkacheva, Runikhina, Kotovskaya, et al., 2017). In 
general, this aggravates the condition of patients and 
worsens the prognosis. 
According to modern concepts, frailty is 
characterized by a decrease in muscle strength, 
endurance and physical activity (Arango-Lopera, et al. 
2013- Prashchayeu, et al. 2016- Boytsov, et al., 2017. 
Tkacheva, Pereverzev, Runikhina, et al., 2017), a 
decrease in body weight (Tkacheva,., 2018, Noskov, et 
al. 2015), development of cognitive disorders, loss of 
motivation and life interests, which leads to the 
increased risk of developing any pathology and death 
(Sychev, 2016, Mubang, Stoltzfus, Cohen, et al., 2015). 
A specific feature of geriatric syndromes, in particular 
frailty, is the multiplicity of pathogenetic mechanisms of 
these conditions development (Raiche, Hebert, Dubois, 
2008., Rymkiewicz, et al. 2016).of a syndrome as a 
combination of symptoms with a single pathogenesis. 
Moreover, in each particular case, various combinations 
of nosological forms can lead to the development of 
specific geriatric conditions. 
For timely diagnosis of geriatric syndromes, it is 
necessary to determine those indicators of laboratory 
and instrumental methods of diagnosis that are most 
associated with age and can serve as peculiar markers 
of the risk of their development. 
In this regard, the analysis and interpretation of 
traditional clinical data obtained during treatment and 
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diagnostic measures indicating the possible 
development of specific geriatric conditions in patients is 
of great importance. It is relevant to identify the age-
associated indicators of the body and assess their 
relationship with geriatric syndromes, which will allow us 
to form a more complete picture of the disease and 
differentially plan treatment, diagnostic and rehabilitation 
measures in elderly and senile patients. 
The purpose of this work is to study age-related 
dynamics of clinical indicators that reflect the basic vital 
systems of the body and assess their impact on the 
development of frailty. 
MATERIAL AND METHODS  
The study included clinically compensated patients 
undergoing inpatient treatment in therapeutic 
departments in connection with the exacerbation of 
chronic diseases of the cardiovascular and 
bronchopulmonary systems of the City Clinical Hospital 
and the hospital for war veterans in the city of Belgorod. 
Severe patients, cancer patients, and patients with 
decompensated therapeutic pathology were excluded 
from the study. 
All patients from the main group (n = 200) underwent 
anthropometric measurements and laboratory 
examinations standard for therapeutic pathology. In 
some patients (additional group (n = 84), the risk of 
developing senile asthenia was assessed using the 
questionnaires “PRISMA-7” and “Questionnaire for 
citizens aged 75 years and older”, which includes the 
scale “Age is not a hindrance” [2, 4, 11, 20], 
echocardiography, wrist dynamometry was performed, 
the peak expiratory flow rate was examined. 
The data obtained was processed using parametric 
statistics methods (estimation of the average value (M), 
the average error of the arithmetic mean (m), the 
significance of differences using Student’s t-test), in 
addition, correlation and regression analysis of the data 
was performed. During the correlation analysis, the 
hypothesis of the normality of the parameter distribution 
in the combined age group was checked, then the 
Pearson correlation coefficient (r) was calculated. The 
correlation was considered weak with a modulus of r less 
than 3, moderate with a value of r more than or equal to 
3, but less than 7, strong - with r greater than or equal to 
7. 
RESULTS AND DISCUSSION 
 Hemostatic profiles at different ages of the main 
group are presented in Table 1. 
Analysis of Table 1 allows to determine the 
parameters of the body, which reliably unidirectionally 
change with patients’ age rising. A decrease in anabolic 
processes in the liver (a decrease in total protein, 
alanine aminotransferase activity, an increase in blood 
glucose), a deterioration in total kidney function (a 
decrease in glomerular filtration rate, hemoglobin, an 
increase in potassium in the blood plasma) are 
observed. Fig. 1 presents a diagram of unidirectional 
dynamics of changes in the studied parameters in the 
groups of elderly and senile patients compared to the 
group of patients of mature and young age, the average 
value of which is accepted as equaling one. 
Table 2 presents data obtained from studying the 
risk of developing frailty and associated sarcopenia 
using the “PRISMA-7” questionnaire and the 
“Questionnaire for citizens aged 75 years and older”, 
wrist dynamometry, peak inspiratory flow rate, 
echocardiography. 
In addition, the presented results of commonly used 
in therapeutic practice biochemical analysis and 
echocardiography reflect the integral function of liver, 
kidneys, and heart. Also, correlation coefficients 
calculated for the studied indicators in the combined age 
group (young and mature age, elderly age, senile age) 
are included in the tables. 
As we can see in Table 2, the risk of frailty 
developing (test “PRISMA-7” and “Questionnaire for is 
sufficiently high (r = 0.6 and r = 0.61, respectively). No 
significant differences between the data from the two 
Table 1. Individual indicators of the body state in different age groups (M±m) 
Indicator 
Young and Mature 
Age 
Elderly Age Senile Age 
Correlation coefficient 
between the indicator and the 
age for the whole group 
Main Group (n=200) 
Number of patients 57 88 55 − 
Age, years 51.6±0.89 66.7±0.38 80.3±0.62 − 
Body mass index, kg/m2 30.6±0.85 29.8±0.51 28.1±0.84* -0.17 
Total protein, g/l 75±1.75 73±1.33 67.3±0.90* -0.37* 
Glucose, mmol/l 6.3±0.27 6.9±0.27 7.5±0.47* 0.20* 
Total cholesterol, mmol/l 5.3±0.59 5.1±0.25 5.5±0.29 0.09 
Bilirubin, mcmol/l 14.4±1.47 13.4±0.88 17.2±2.36 0.06 
Alanine aminotransferase, u/l 28.4±1.93 25.8±1.36 16.9±1.12* -0.35* 
Aspartate aminotransferase, u/l 26.6±1.95 27.1±1.80 23.8±1.41 -0.21* 
Potassium, mmollл 4.1±0.05 4.2±0.05 4.7±0.09* 0.48* 
Urea, mol/l 6.9±0.47 7.1±0.57 7.3±0.55 0.21* 
Creatinine, mcmol/l 92.4±4.73 94.3±3.50 100.6±3.42 0.06 
Glomerular filtration rate (Cockcroft-Gault), ml/min 105±3.51 84±2.78* 53±2.41* -0.66* 
Hemoglobin, g/l 141±1.96 135±1.7* 122±2.34* -0.36* 
The sign “*” marks the indicators in the groups of the elderly and senile age, reliably different from the indicators in the groups of adult and young age (p 
<0.05) and reliable correlation coefficients in the combined group (p <0.01). 
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tests were noted. The dynamics of changes are 
presented in Fig. 2. 
 
Our data showed (Table 2) that there were no 
univocal age-related changes in the state of the 
myocardium. In patients of senile age, the final diastolic 
volume is significantly lower than in elderly and adult 
patients. There is a reliable moderate correlation 
between age and final diastolic volume of the left 
ventricle, as well as a weak, negative correlation 
between age and myocardial mass. In general, it can be 
noted that according to the data of echocardiography the 
heart condition in senile patients is somewhat better 
than in elderly patients. The latter fact requires further 
research and, possibly, is associated with the fact that 
patients with better indicators of myocardial condition 
have longer life span. 
The latter indicator depends not only on bronchial 
passability, but also on the strength of the intercostal 
muscles. The degree of correlation between these 
indicators is comparable with the indicators of screening 
tests for assessing the risk of frailty development, which 
reflects their close pathogenetic relationship. The 
greatest (“strong”, r=-0.71) correlation with age was 
found for the indicator of muscle strength assessment 
during wrist dynamometry, which reasonably finds its 
application in screening of geriatric syndromes such as 
sarcopenia and frailty (Fig. 3). 
In general, it is clear that the greatest age-related 
deviations are observed in such indicators as muscle 
strength, glomerular filtration rate, and risk of frailty 
developing. Total protein, potassium, hemoglobin, the 
activity of alanine aminotransferase and blood plasma 
glucose noticeably change with age. The results of our 
study show that the age-associated integral indicators, 
such as the risk of frailty development, muscle strength, 
weight loss, change more significantly than individual 
biochemical parameters. This confirms the multiple 
 
Fig. 1. The relative decrease in individual indicators of the body in different age groups 
Table 2. Individual indicators of the body state at different ages of the additional group (M±m) 
Indicator 
Young and Adult 
Age 
Elder Age Senile Age 
Correlation coefficient 
between the indicator and the 
age for the whole group 
Additional Group (n=84) 
Number of patients 13 27 43 − 
Age, years 51±2.19 66±0.71 82±0.89 − 
“PRISMA-7” test, scores 0.9±0.23 2.1±0.16* 3.2±0.27* 0.60* 
Questionnaire for citizens aged 75 years and 
older, scores 
1.9±0.31 2.6±0.22 4.2±0.35* 0,61* 
Wrist dynamometry, daN 37±3.68 18±2.08* 12± 0.88* -0.71* 
Peak expiratory flow rate, l/min 422±35.80 254±22.65* 173±16.02* -0.61* 
Left ventricle end-diastolic dimension, cm 5.2±0.20 5.2±0.09 4.7±0.09* -0.46* 
Left ventricle end-systolic dimension, cm 3.6±0.24 3.6±0.14 3.3±0.07 -0.24 
Interventricular septum thickness, cm 1.4±0.04 1.5±0.03 1.5±0.03 0.08 
Left ventricle posterior wall thickness, cm 1.3±0.03 1.4±0.02* 1.4±0.03* 0.09 
Myocardial mass, g 381±27.73 401±15.12 342±13.58 -0.29* 
Left ventricular myocardium mass index, g/ m2 186±9.97 196±7.15 197±7.21 0.01 
Left ventricle ejection fraction, % 55±2.58 57±2.08 59±1.27 0.13 
The sign “*” marks the indicators in the groups of the elderly and senile age, reliably different from the indicators in the groups of adult and young age (p 
<0.05) and reliable correlation coefficients in the combined group (p <0.01) 
 
 




nature of pathogenetic mechanisms and the role of 
comorbidity in the development of geriatric syndromes. 
A correlation analysis was performed to study the 
influence of individual indicators on each other. 
Correlation coefficients were calculated not only 
between age and those indicators, but also between the 
indicators themselves. The main results are presented 
in Table 3. 
A strong negative correlation (r=-0.71) was found 
between muscle strength according to the wrist 
dynamometry and age. In addition, a fairly high 
correlation was found between age and the likelihood of 
frailty development according to the “PRISMA-7” test 
(r=0.60). The strong positive correlation between the 
wrist dynamometry and the peak expiratory flow rate 
(r=0.81) reflects the fact that both indicators are related 
to the muscle strength – hands and chest, respectively. 
 
Fig. 2. Results of tests “PRISMA-7” and “Questionnaire for citizens aged 75 years and older “ in patients of different age 
groups 
 
Fig. 3. Age-related dynamics of the patients’ muscular strength according to wrists dynamometry 
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The patient’s body weight shows a moderate correlation 
with muscle strength, heart condition (ejection fraction, 
myocardial mass), kidneys condition (glomerular 
filtration rate, potassium, hemoglobin), which reflects the 
natural anatomical and physiological relations. Muscle 
strength (dynamometry, peak expiratory flow rate) is 
most strongly related to glomerular filtration rate (r=0.62 
and r=0.46, respectively). Fig. 4 illustrates the 
relationship between the muscle strength of hands and 
glomerular filtration rate in patients of different ages. 
Myocardial mass and ejection fraction of the left 
ventricle show a moderate negative relationship with the 
potassium content in blood plasma (r=-0.34 and r=-0.41, 
respectively). A reliable but weak correlation was found 
between the risk of frailty development according to the 
“PRISMA-7” test, muscle strength and glomerular 
filtration rate (r=-0.26 and r=-0.22, respectively). 
CONCLUSION 
Clinical parameters of the body, such as muscle 
strength, glomerular filtration rate, some biochemical 
indicators (total protein, potassium, hemoglobin, alanine 
aminotransferase activity and blood plasma glucose), 
which are most closely associated with age, were 
determined. Changes in these parameters must be 
taken into account when assessing the condition of 
elderly and senile patients, as well as in predicting the 
development of geriatric syndromes for them. 
The study revealed a significant contribution of 
decreased total renal function (a decrease in glomerular 
filtration and blood hemoglobin rate and increase in 
potassium) and anabolic liver activity (a decrease in total 
protein, alanine aminotransferase activity) in the 
development of age-related changes in the body and in 
the risk of frailty development. Management and 
correction of these systems must be taken into account 
when developing therapeutic treatment and 
rehabilitation programs for elderly and senile patients. 
The analysis of age-related body indicators 
dynamics showed that integral indicators, such as the 
risk of frailty development, body weight and muscle 
strength, change significantly more over time than 
individual indicators of homeostasis, which reflects the 
multiple nature of pathogenetic mechanisms and the 























Age 0,60 -0.51* -0.71* -0.61* 0.13 -0.29* -0.37* 0.48* -0.36* -0.66* 
«PRISMA-7»  -0.08 -0.26* -0.21* 0.02 -0.05 -0.15 0.14 -0.12 -0.22* 
Body mass   0.37* 0.36* -0.35* 0.52* 0.31* -0.38* 0.32* 0.47* 
Wrist 
dynamometry 
   0.81* -0.10 0.04 0.25 -0.30* 0.39* 0.62* 
Peak expiratory 
Flow Rate 
    0.03 0.05 0.31* -0.31* 0.37* 0.46* 
Left Ventricle 
Ejection Fraction 
     -0.35* -0.06 -0.41* 0.22 0.25 
Myocardial Mass       0.13 -0.34* 0.06 0.22 
Sign “*” marks reliable correlation coefficients (p <0.01) 
 
Fig. 4. Muscle strength of hands depending on the glomerular filtration rate in patients of different ages 
 
 




role of comorbidity in the development of geriatric 
syndromes, particularly in the development of asthenia. 
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